Rhodamine-functionalised rhodium( iii ) complexes: dual role as bioimaging agents and controllable reactive oxygen species photosensitisers for photocytotoxicity applications
Open Access
- 8 October 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (46) , 22127-22135
Abstract
Compared to well-developed iridium(III) complexes, cyclometallated rhodium(III) complexes are underexplored as bioimaging reagents and photosensitisers, primarily due to the presence of non-emissive low-lying d–d excited states that limit their photophysical properties. In this work, a series of rhodamine-containing rhodium(III) complexes [Rh(N^C)2(bpy-Rho)](PF6)2 was designed and synthesised to circumvent this problem. The incorporation of a rhodamine unit into cyclometallated rhodium(III) complexes endowed them with effective bioimaging and considerable reactive oxygen species (ROS) sensitisation capabilities upon low-energy photoexcitation. Time-resolved transient absorption spectroscopy of the complexes revealed a long-lived dark triplet state of rhodamine that was responsible for the enhanced ROS photosensitisation. An energy cascade pathway was proposed for the complexes, involving energy transfer from a rhodamine singlet excited state (S1) to a Rh(N^C)2-based triplet excited state (T1’), and ultimately to the lowest-lying rhodamine-based triplet excited state (T1). Through a judicious choice of cyclometallating ligands, the energy cascade efficiency can be modulated to achieve a delicate balance between fluorescence and ROS photosensitisation. Furthermore, the complexes specifically accumulated in the mitochondria and showed excellent photocytotoxicity via inducing pyroptosis, highlighting their potential as theranostic agents for bioimaging and photodynamic therapy.Keywords
Funding Information
- National Natural Science Foundation of China (21771099, N_CityU104/21)
- Science, Technology and Innovation Commission of Shenzhen Municipality (JCYJ20190809165411528)
- Research Grants Council, University Grants Committee (CityU 11309423, CityU11304524, N_CityU104/21)
- Innovation and Technology Commission (“Laboratory for Synthetic Chemistry and Chemical Biology” under the Health@InnoHK Programme)
This publication has 66 references indexed in Scilit:
- Apoptosis‐Sensitizing Tumor Nanomedicine by Regulating Pyroptosis‐Associated Inflammatory Cell DeathAdvanced Functional Materials, 2024
- Molecular Engineering of Plasma Membrane and Mitochondria Dual‐Targeted NIR‐II AIE Photosensitizer Evoking Synergetic Pyroptosis and ApoptosisAdvanced Materials, 2023
- A Biodegradable Iridium(III) Coordination Polymer for Enhanced Two‐Photon Photodynamic Therapy Using an Apoptosis–Ferroptosis Hybrid PathwayAngewandte Chemie International Edition, 2022
- Phosphorogenic Iridium(III) bis‐Tetrazine Complexes for Bioorthogonal Peptide Stapling, Bioimaging, Photocytotoxic Applications, and the Construction of Nanosized HydrogelsAngewandte Chemie International Edition, 2022
- A Carbonic Anhydrase IX (CAIX)‐Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti‐Tumor ImmunityAngewandte Chemie International Edition, 2021
- Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer ImmunotherapyAdvanced Science, 2021
- Activation of Pyroptosis by Membrane‐Anchoring AIE Photosensitizer Design: New Prospect for Photodynamic Cancer Cell AblationAngewandte Chemie International Edition, 2021
- An Iridium (III) Complex Bearing a Donor–Acceptor–Donor Type Ligand for NIR‐Triggered Dual PhototherapyAdvanced Functional Materials, 2020
- Selective Inhibition of Lysine‐Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple‐Negative Breast Cancer TherapyAngewandte Chemie International Edition, 2018
- Antagonizing STAT3 Dimerization with a Rhodium(III) ComplexAngewandte Chemie International Edition, 2014